Results 241 to 250 of about 4,275,878 (309)

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry

open access: yesArthritis Care &Research, EarlyView.
Objective Mycophenolate mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon because of the lower fibrotic burden and the predominance of vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

Reconsidering cytoreductive therapy in high-risk pediatric mastocytosis: From diffuse cutaneous to smoldering systemic disease. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Giavina-Bianchi M   +5 more
europepmc   +1 more source

Systemic Inflammation and Structural Retinal Damage on OCT in Acute Non-Arteritic Central Retinal Artery Occlusion-A Retrospective Study. [PDF]

open access: yesInt J Mol Sci
Nica AM   +11 more
europepmc   +1 more source

Genetic variants associated with systemic inflammatory disease associate with temporomandibular symptoms with or without periodontitis. [PDF]

open access: yesPLoS One
Lucas C   +10 more
europepmc   +1 more source

Locoregional delivery of CAR T cells in high-grade gliomas: a systematic analysis of safety, efficacy, and emerging biomarkers of response. [PDF]

open access: yesJ Immunother Cancer
Ramsoomair CK   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy